Cargando…
Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines
PURPOSE: Noonan syndrome with multiple lentigines (NSML) is an autosomal dominant disorder presenting with hypertrophic cardiomyopathy (HCM). Up to 85% of NSML cases are caused by mutations in the PTPN11 gene that encodes for the Src homology 2 (SH2) domain-containing protein tyrosine phosphatase 2...
Autores principales: | Yi, Jae-Sung, Perla, Sravan, Huang, Yan, Mizuno, Kana, Giordano, Frank J., Vinks, Alexander A., Bennett, Anton M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270274/ https://www.ncbi.nlm.nih.gov/pubmed/33689087 http://dx.doi.org/10.1007/s10557-021-07169-z |
Ejemplares similares
-
Hypertrophic cardiomyopathy in an adult patient with Noonan syndrome with multiple lentigines
por: Rivero‐García, Pamela, et al.
Publicado: (2023) -
In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy
por: Wang, Jianxun, et al.
Publicado: (2017) -
A rare mutation in a patient with Noonan syndrome with multiple lentigines
por: Blanco-Cintrón, Manuel E., et al.
Publicado: (2023) -
Treatment of Facial Lentigines in an Adult Female Patient Suspected with Leopard Overlap Noonan Syndrome
por: Ruchiatan, Kartika, et al.
Publicado: (2023) -
Double‐chambered right ventricle complicated by hypertrophic obstructive cardiomyopathy diagnosed as Noonan syndrome
por: Yamamoto, Masahiro, et al.
Publicado: (2020)